BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 31817878)

  • 41. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular Vesicles from Human Papilloma Virus-Infected Cervical Cancer Cells Enhance HIV-1 Replication in Differentiated U1 Cell Line.
    Ranjit S; Kodidela S; Sinha N; Chauhan S; Kumar S
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32098055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen.
    Šrajer Gajdošik M; Kovač Peić A; Begić M; Grbčić P; Brilliant KE; Hixson DC; Josić D
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural insights into understudied human cytochrome P450 enzymes.
    Machalz D; Pach S; Bermudez M; Bureik M; Wolber G
    Drug Discov Today; 2021 Oct; 26(10):2456-2464. PubMed ID: 34161845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Network analysis and cross species comparison of protein-protein interaction networks of human, mouse and rat cytochrome P450 proteins that degrade xenobiotics.
    Karthikeyan BS; Akbarsha MA; Parthasarathy S
    Mol Biosyst; 2016 Jun; 12(7):2119-34. PubMed ID: 27194593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Porphyrinogenic xenobiotic-induced N-alkylprotoporphyrin IX formation: a bioassay utilizing chick embryo hepatic ferrochelatase.
    Gamble JT; Nakatsu K; Marks GS
    J Pharmacol Toxicol Methods; 2002; 47(1):25-32. PubMed ID: 12387936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions.
    He R; Dai Z; Finel M; Zhang F; Tu D; Yang L; Ge G
    Drug Metab Dispos; 2023 Oct; 51(10):1254-1272. PubMed ID: 37349113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P450-activated prodrugs: targeted drug delivery.
    Huttunen KM; Mähönen N; Raunio H; Rautio J
    Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
    Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
    Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition and induction of CYP enzymes in humans: an update.
    Hakkola J; Hukkanen J; Turpeinen M; Pelkonen O
    Arch Toxicol; 2020 Nov; 94(11):3671-3722. PubMed ID: 33111191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphorylation of xenobiotic-metabolizing cytochromes P450.
    Oesch-Bartlomowicz B; Oesch F
    Anal Bioanal Chem; 2008 Nov; 392(6):1085-92. PubMed ID: 18704375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of extracellular microvesicles in drug metabolism.
    Conde-Vancells J; Gonzalez E; Lu SC; Mato JM; Falcon-Perez JM
    Expert Opin Drug Metab Toxicol; 2010 May; 6(5):543-54. PubMed ID: 20192903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular Vesicles in Metabolism and Metabolic Diseases.
    Marzan AL; Nedeva C; Mathivanan S
    Subcell Biochem; 2021; 97():393-410. PubMed ID: 33779925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the microbiome and psychosocial stress in the expression and activity of drug metabolizing enzymes in mice.
    Zemanová N; Anzenbacher P; Zapletalová I; Jourová L; Hermanová P; Hudcovic T; Kozáková H; Vodička M; Pácha J; Anzenbacherová E
    Sci Rep; 2020 May; 10(1):8529. PubMed ID: 32444678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers.
    Pidkovka N; Rachkevych O; Belkhiri A
    Oncotarget; 2021 Feb; 12(4):379-391. PubMed ID: 33659048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel extrahepatic cytochrome P450s.
    Karlgren M; Miura S; Ingelman-Sundberg M
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):57-61. PubMed ID: 15987645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology.
    Lee Y; Kim JH
    Clin Mol Hepatol; 2022 Oct; 28(4):706-724. PubMed ID: 35232008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Appearance of claudin-5
    Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
    J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Three novel cytochrome P450 genes identified in the marine polychaete Perinereis nuntia and their transcriptional response to xenobiotics.
    Zheng S; Chen B; Qiu X; Lin K; Yu X
    Aquat Toxicol; 2013 Jun; 134-135():11-22. PubMed ID: 23542651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.